FDA Classifies Ultrasound Anatomy Labeling Device for Regional Anesthesia as Class II
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The rule places real-time ultrasound anatomy visualization and labeling devices used for ultrasound-guided regional anesthesia into FDA class II, with special controls. This means these devices will be regulated as moderate-risk medical devices rather than being treated as high-risk devices by default. Medical device manufacturers may face a clearer and less burdensome approval path, while still having to meet FDA safety and performance controls. Hospitals, anesthesiology teams, and patients could see faster access to tools that help identify anatomy during regional anesthesia procedures.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Classifies the device type as FDA class II with special controls
- Moves the device away from the default class III high-risk pathway
- Creates a clearer regulatory route for similar ultrasound-guided anesthesia support devices
Obligations
What this law requires
Manufacturers of real-time ultrasound anatomy visualization and labeling devices for ultrasound-guided regional anesthesia must comply with FDA class II special controls applicable to this device type once marketing such devices in the United States.